Practice of pharmacy; requiring licensure of certain out-of-state pharmacies; requiring certain inspections; providing administrative remedies and penalties. Effective date.
SB 2023 creates a new licensing and inspection framework for out-of-state pharmacies that ship drugs into Oklahoma. Under the bill, these pharmacies must be licensed by the State Board of Pharmacy and comply with Oklahoma pharmacy laws, Board rules, and related standards. The measure also authorizes the Board to discipline these pharmacies for specified violations, including improper technician-to-pharmacist ratios, failure to follow storage and delivery guidelines, and other pharmacy-related violations identified by the Board.
The bill requires the Board to conduct an initial on-site inspection of covered out-of-state pharmacies within six months of the act’s effective date for existing operations, or as soon as practicable for new entrants. It also mandates annual on-site inspections thereafter. If violations are found, the Board must notify the pharmacist in charge, order correction, and may impose fines of up to $50,000 per violation. A follow-up inspection must occur within 90 days, and if violations are not corrected, the Board must permanently revoke the pharmacy’s license and the pharmacist in charge’s license. The bill further requires that inspections be performed directly by Board inspectors and paid for by the pharmacy, rather than relying solely on inspections by other states.
The bill’s impact would be to extend Oklahoma’s regulatory reach over mail-order, online, and other nonresident pharmacies that dispense into the state, creating new compliance obligations and enforcement tools. It would add a new section to Title 59 of the Oklahoma Statutes and strengthen the Board’s authority to inspect, fine, and revoke licenses for pharmacies operating outside Oklahoma but serving Oklahoma patients.
Overall sentiment appears neutral to supportive based on the bill’s introduction and referral status, with no recorded committee debate or votes in the provided materials. The bill’s structure suggests a consumer-safety and enforcement focus, emphasizing direct state oversight of drug shipping pharmacies. Likely points of contention include the cost and burden of repeated on-site inspections, the size of the fines, the requirement that Oklahoma inspectors conduct the inspections, and the potential impact on out-of-state or mail-order pharmacy operations.
The bill would add Section 353.8a to Title 59 and require out-of-state pharmacies that ship drugs into Oklahoma to obtain licensure from the State Board of Pharmacy. It expands the Board’s enforcement authority by defining violations, mandating initial and annual on-site inspections, authorizing fines up to $50,000 per violation, and requiring permanent revocation if violations are not corrected. It also shifts inspection costs to the pharmacy and limits reliance on inspections performed by other states.
No committee transcript or vote record is provided, so there is no documented floor or committee debate to indicate partisan or stakeholder positions. Based on the bill text, the measure appears to be framed as a patient-safety and regulatory-enforcement bill, which may draw support from pharmacy regulators and consumer advocates. At the same time, out-of-state pharmacies and mail-order pharmacy operators may view it as burdensome due to licensing, inspection, and penalty provisions.
The main points of contention are likely to be the bill’s regulatory burden and enforcement severity. Out-of-state pharmacies may object to mandatory Oklahoma licensure, direct inspections by Oklahoma inspectors, annual and follow-up inspections, and the requirement that pharmacies pay for those inspections. The $50,000-per-violation fine and permanent revocation provisions may also be viewed as harsh, especially because the Board is given broad discretion to identify additional violations under its rules and standards.